$90.5 Million is the total value of SV Health Investors, LLC's 6 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ENTL | Sell | ENTELLUS MED INC | $40,801,000 | -38.4% | 2,956,456 | -15.3% | 45.06% | -19.2% |
| KALV | KALVISTA PHARMACEUTICALS INC | $20,146,000 | +10.5% | 2,579,490 | 0.0% | 22.25% | +44.9% | |
| OCUL | OCULAR THERAPEUTIX INC | $14,896,000 | +10.9% | 1,605,207 | 0.0% | 16.45% | +45.4% | |
| TRXC | TRANSENTERIX INC | $9,131,000 | -6.9% | 7,546,692 | 0.0% | 10.08% | +22.1% | |
| CATB | CATABASIS PHARMACEUTICALS IN | $4,572,000 | -55.7% | 2,857,667 | 0.0% | 5.05% | -41.9% | |
| EVAR | LOMBARD MED INC | $995,000 | +30.1% | 1,275,779 | 0.0% | 1.10% | +70.7% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- SVLSF IV, LLC #1
- SV Life Sciences Fund IV (GP), L.P. #2
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-01
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TRANSENTERIX, INC. | 27 | Q4 2020 | 24.0% |
| OCULAR THERAPEUTIX, INC. | 24 | Q2 2020 | 35.9% |
| KALVISTA PHARMACEUTICALS INC | 17 | Q4 2020 | 31.0% |
| DECIPHERA PHARMACEUTICALS INC | 17 | Q3 2021 | 31.0% |
| CATABASIS PHARMACEUTICALS, INC. | 15 | Q4 2018 | 18.2% |
| X4 PHARMACEUTICALS INC | 15 | Q3 2022 | 3.2% |
| BICYCLE THERAPEUTICS PLC | 14 | Q3 2022 | 65.4% |
| SUTRO BIOPHARMA INC | 14 | Q4 2021 | 19.1% |
| ENTELLUS MED INC | 12 | Q4 2017 | 64.4% |
| AVROBIO INC | 12 | Q1 2021 | 41.6% |
View SV Health Investors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-07 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-14 |
View SV Health Investors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.